Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03833674 · ClinicalTrials.gov registry record · NA
FLO2 for Recovery After SCI
A NA study of Spinal Cord Injury (SCI), sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT03833674: Completed NA study of Spinal Cord Injury (SCI), sponsored by University of Florida.
NCT03833674 is a NA study of Spinal Cord Injury (SCI) that has completed, run by University of Florida. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03833674, a NA study of Spinal Cord Injury (SCI), has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
Acute intermittent hypoxia (AIH) involves short (\~1-2min) bouts of breathing low oxygen air to stimulate spinal neuroplasticity. Studies in rodents and humans indicate that AIH improves motor function after spinal cord injury (SCI). This study will use a double blind, cross-over design to test if the combination of AIH and respiratory strength training improves breathing function more than either approach alone in adults with chronic SCI.
Primary Outcome
Maximal inspiratory pressure is a non-invasive measure of the maximal force achieved when breathing in against an occluded airway.
Conditions Studied
Interventions
- OTHER Daily AIH Block
- OTHER Sham dAIH Block
- OTHER Respiratory Strength Training Block
- OTHER AIH + Strength Training Block
Study Locations (1)
Florida
- Brooks Rehabilitation Hospital - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2020-08-15 |
| Est. Completion | 2024-02-20 |
| Phase | NA |
What the finished NCT03833674 record still lists
NCT03833674 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Spinal Cord Injury (SCI) appearing as the primary indexed condition, and to 4 interventions - of which Daily AIH Block is the first listed.
NCT03833674 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03833674 about?
NCT03833674 is a clinical study titled "FLO2 for Recovery After SCI". Acute intermittent hypoxia (AIH) involves short (\~1-2min) bouts of breathing low oxygen air to stimulate spinal neuroplasticity. Studies in rodents and humans indicate that AIH improves motor function after spinal cord injury (SCI). This study will use a double blind, cross-over design to test if t...
What is the current status of trial NCT03833674?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2020-08-15. Estimated completion is 2024-02-20.
What conditions does trial NCT03833674 study?
This clinical trial studies the following conditions: Spinal Cord Injury (SCI).
What interventions are being tested in trial NCT03833674?
The interventions under investigation include: Daily AIH Block (OTHER), Sham dAIH Block (OTHER), Respiratory Strength Training Block (OTHER), AIH + Strength Training Block (OTHER).
Who is sponsoring clinical trial NCT03833674?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03833674 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury (SCI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03833674's enrollment target sits among peer trials
43 1435th of 2000 higher than 565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI